Jeanne S Mandelblatt
Overview
Explore the profile of Jeanne S Mandelblatt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
170
Citations
5512
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goddard K, Feuer E, Mandelblatt J, Meza R, Holford T, Jeon J, et al.
JAMA Oncol
. 2024 Dec;
11(2):162-167.
PMID: 39636625
Importance: Cancer mortality has decreased over time, but the contributions of different interventions across the cancer control continuum to averting cancer deaths have not been systematically evaluated across major cancer...
2.
Lai C, Lee M, Bobek O, Le-Rademacher J, Mandrekar S, Mandrekar S, et al.
Blood Adv
. 2024 Nov;
9(2):398-401.
PMID: 39602659
No abstract available.
3.
Mandelblatt J, Antoni M, Bethea T, Cole S, Hudson B, Penedo F, et al.
J Natl Cancer Inst
. 2024 Aug;
117(3):406-422.
PMID: 39196709
The central premise of this article is that a portion of the established relationships between social determinants of health and racial and ethnic disparities in cancer morbidity and mortality is...
4.
Stout N, Miglioretti D, Su Y, Lee C, Abraham L, Alagoz O, et al.
JAMA Intern Med
. 2024 Aug;
184(10):1222-1231.
PMID: 39186304
Importance: Information on long-term benefits and harms of screening with digital breast tomosynthesis (DBT) with or without supplemental breast magnetic resonance imaging (MRI) is needed for clinical and policy discussions,...
5.
Trentham-Dietz A, Hunter Chapman C, Jayasekera J, Lowry K, Heckman-Stoddard B, Hampton J, et al.
JAMA
. 2024 Apr;
331(22):1947-1960.
PMID: 38687505
Importance: The effects of breast cancer incidence changes and advances in screening and treatment on outcomes of different screening strategies are not well known. Objective: To estimate outcomes of various...
6.
Mandelblatt J, Mainor C, Hudson B
JAMA
. 2024 Apr;
331(20):1709-1711.
PMID: 38683570
No abstract available.
7.
McDeed A, Van Dyk K, Zhou X, Zhai W, Ahles T, Bethea T, et al.
JNCI Cancer Spectr
. 2024 Mar;
8(2).
PMID: 38556480
Purpose: Cancer survivors commonly report cognitive declines after cancer therapy. Due to the complex etiology of cancer-related cognitive decline (CRCD), predicting who will be at risk of CRCD remains a...
8.
9.
Caswell-Jin J, Sun L, Munoz D, Lu Y, Li Y, Huang H, et al.
JAMA
. 2024 Jan;
331(3):233-241.
PMID: 38227031
Importance: Breast cancer mortality in the US declined between 1975 and 2019. The association of changes in metastatic breast cancer treatment with improved breast cancer mortality is unclear. Objective: To...
10.
Jayasekera J, Stein S, Wilson O, Wojcik K, Kamil D, Rossell E, et al.
J Gen Intern Med
. 2023 Nov;
39(3):428-439.
PMID: 38010458
Background: Guidelines recommend shared decision-making (SDM) around mammography screening for women ≥ 75 years old. Objective: To use microsimulation modeling to estimate the lifetime benefits and harms of screening women...